Concepedia

John L. Stebbins

JL

35

Publications

2.1K

Citations

27

H-Index

2004

Active since

Affiliations

Sanford Burnham Prebys Medical Discovery Institute(Current)

Virginia Commonwealth University

Cedars-Sinai Medical Center

Bioscience Research

Johns Hopkins Medicine

John L. Stebbins is an author at Sanford Burnham Prebys Medical Discovery Institute specializing in medicine, drug discovery, and pharmacology.

Top concepts

MedicinePharmacologyDrug DiscoveryNatural SciencesMedicinal ChemistryBiochemistryCell BiologyCancer ResearchRadiation OncologyTumor Biology

Publications per year

2004–2019

35

Publications

35

Identification of a new JNK inhibitor targeting the JNK-JIP interaction site

John L. Stebbins, Surya K. De, Thomas Machleidt et al. · Proceedings of the National Academy of Sciences · 2008 · 186 citations · Full text

Jnk-jip Interaction Site, Insulin Signaling, Signaling Pathway +19

Standardizing Size- and Shape-Controlled Synthesis of Monodisperse Magnetite (Fe<sub>3</sub>O<sub>4</sub>) Nanocrystals by Identifying and Exploiting Effects of Organic Impurities

Liang Qiao, Zheng Fu, Ji Li et al. · ACS Nano · 2017 · 150 citations

Regulation of Nur77 nuclear export by c-Jun N-terminal kinase and Akt

Y-H Han, Xihua Cao, Bingzhen Lin et al. · Oncogene · 2006 · 143 citations

Signal Transduction, Signaling Pathway, Molecular Pathway +11

Novel MT1-MMP Small-Molecule Inhibitors Based on Insights into Hemopexin Domain Function in Tumor Growth

Albert G. Remacle, Vladislav S. Golubkov, Sergey A. Shiryaev et al. · Cancer Research · 2012 · 133 citations · Full text

Mt1-mmp Mutant, Cancer Biology, Tumor Biology +17

Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to <i>mda</i> -7/IL-24–mediated toxicity

Rupesh Dash, Belal Azab, Bridget A. Quinn et al. · Proceedings of the National Academy of Sciences · 2011 · 123 citations

Rows per page

1–5 of 35